Clinical trials: Benign Hyperplasia of Prostate
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia
Database for the Assessment of Efficacy and Safety of BPH Treatment
This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS).
- Trial name
- KSSG-BPH-REG (NCT03521648)
- Testing
- PAE, TURP, Other
- Where
- Switzerland
- Volunteers
- 500 people
- Sponsor
- Dominik Abt
Prostatic Hyperplasia
WEUSKOP5723: Prostate Cancer Study
This retrospective cohort study will assess the association of benign prostatic hyperplasia (BPH) treatment (5-alpha reductase inhibitors (5ARI) and alpha-blocker medications) with the occurrence of prostate cancer related…
- Trial name
- NCT01767363
- Testing
- 5-alpha reductase inhibitors, Alpha-blockers
- Volunteers
- 1 people
- Sponsor
- GlaxoSmithKline
Nocturia, Benign Prostatic Hypertrophy (BPH)
Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)
The purpose of this study is to establish the dose response relationship of VA106483 and nocturnal urine volumes in a population of elderly male subjects with Benign Prostatic Hypertrophy (BPH) who are likely to present with…
- Trial name
- NCT01330927
- Testing
- VA106483
- Where
- Germany
- Volunteers
- 30 people
- Sponsor
- Vantia Ltd
Benign Prostatic Hyperplasia, Bladder Outlet Obstruction
Urinary CTGF in Benign Prostatic Obstruction
Benign prostatic obstruction (BPO) is one of the most common causes of bladder outlet obstruction (BOO) and may lead to progressive structural and functional alterations in the bladder over time.
- Conditions
- Benign Prostatic Hyperplasia, Bladder Outlet Obstruction, Lower Urinary Tract Symptom
- Trial name
- NCT07416981
- Volunteers
- 50 people
- Sponsor
- Tarik Emre Sener
Benign Prostatic Hyperplasia
RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up
The objective of the RELIEF Study is to compare the safety, effectiveness and patient experience outcomes in real-world subjects treated with different modalities for symptomatic BPH.
- Trial name
- RELIEF (NCT05784558)
- Testing
- UroLift System, Watchful Waiting or BPH Medications, Other Surgical Intervention
- Where
- United States
- Sponsor
- NeoTract, Inc.
Prostatic Hyperplasia
Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)
Study to assess efficacy, tolerability and safety parameters of a one month ALNA® - treatment after switch from Terazosin-treatment
- Trial name
- NCT02244333
- Testing
- ALNA®
- Volunteers
- 4,575 people
- Sponsor
- Boehringer Ingelheim
Benign Prostatic Hyperplasia
Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP
Holmium laser enucleation (HOLEP) has became a standard of treatment of large prostates that indicates surgery. HOLEP is widely used nowadays. Many settings are used but no optimal setting was world wide adopted.
- Trial name
- NCT05678452
- Testing
- HOLEP for treating BPH
- Where
- Egypt
- Volunteers
- 200 people
- Sponsor
- Al-Azhar University
Benign Prostatic Hyperplasia (BPH)
Aquablation vs. Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia in Medium to Large Size Prostates
Benign prostatic hyperplasia (BPH) is one of the most common diseases in men. As BPH progresses, surgical treatments often become necessary.
- Trial name
- ATHLETE (NCT04560907)
- Testing
- Aquablation, HoLEP
- Where
- Switzerland
- Volunteers
- 120 people
- Sponsor
- Dr. med. Gautier Müllhaupt
Prostatic Hyperplasia
Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia
To evaluate the effectiveness of the use of teleconsultation in qualifying counter-reference between tertiary and primary care for patients with stable benign prostatic hyperplasia (BPH) symptoms.
- Trial name
- NCT02947958
- Testing
- Teleconsultation, Hospital (control)
- Where
- Brazil
- Volunteers
- 299 people
- Sponsor
- Hospital de Clinicas de Porto Alegre
Prostatic Hyperplasia, Acute Urinary Retention
ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH
To assess the efficacy of alfuzosin 10mg OD in the management of acute urinary retention associated with BPH. To assess the safety of alfuzosin in this population and health care consumption.
- Trial name
- NCT00290030
- Testing
- Alfuzosin
- Volunteers
- 800 people
- Sponsor
- Sanofi
BPH (Benign Prostatic Hyperplasia)
Impact of Kegel Exercise on Patient Outcomes Post TURP
how kegel exercise will improve patient outcomes by reducing post TURP LUTs , improve patient performance status and improve patient self esteem
- Trial name
- NCT06948604
- Testing
- Exercise
- Volunteers
- 92 people
- Sponsor
- Assiut University
Prostatic Hyperplasia, Benign
A 3 Months Duration Interventional Study Comparing Hemodynamic Parameters Between Bolus and Fractionated Group.
The goal of this study is to compare the intraoperative hemodynamic status, characteristics of block of fractionated versus single bolus dose of Hyperbaric Bupivacaine in patient undergoing Transurethral Resection of…
- Trial name
- NCT06620614
- Testing
- 0.5% Heavy Bupivacaine
- Where
- Nepal
- Volunteers
- 72 people
- Sponsor
- National Academy of Medical Sciences, Nepal
Acute Urinary Retention, Benign Prostate Obstruction
Early Versus Delayed Trial Without Catheter in Men With Acute Urinary Retention.
Acute urinary retention (AUR) is a sudden and painful condition. It occurs when a person is unable to urinate. In men, AUR is most often caused by an enlarged prostate, known as benign prostatic hyperplasia (BPH), which blocks…
- Conditions
- Acute Urinary Retention, Benign Prostate Obstruction, Benign Prostate Hyperplasia, Benign Prostate Hypertrophy(BPH)
- Trial name
- RELIEF (NCT07283484)
- Testing
- TWOC after 3 days, TWOC after 14 days
- Where
- 11 sites in Netherlands
- Volunteers
- 478 people
- Sponsor
- Liselot Ribbert
Ischaemic Heart Disease (IHD), Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia and Ischemic Heart DIsease
To examine the dynamics of 24 - hours ECG monitoring parameters (Holter monitoring) in patients with ischaemic heart disease (IHD) before and after treatment of voiding dysfunctions resulted from benign prostatic hyperplasia…
- Conditions
- Ischaemic Heart Disease (IHD), Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms (LUTS)
- Trial name
- NCT03856242
- Testing
- Tamsulosin Oral Capsule, TURP
- Volunteers
- 83 people
- Sponsor
- I.M. Sechenov First Moscow State Medical University
Benign Prostatic Hyperplasia
Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
A new drug for the treatment of benign prostatic hyperplasia is compared with placebo and tamsulosin (a drug belonging to the same therapeutic class) for to determine if it is safe and effective (the first phase of the study…
- Trial name
- NCT00359905
- Testing
- Silodosin, Tamsulosin
- Where
- United Kingdom
- Volunteers
- 1,228 people
- Sponsor
- RECORDATI GROUP
Benign Prostatic Hyperplasia
Safety and Feasibility of the XFLO Expander System (Mercury)
To demonstrate the safety and feasibility of the Mercury Expander system and procedure to treat patients with lower urinary tract symptoms (LUTS) secondary to urinary outflow obstruction from benign prostatic hyperplasia.
- Trial name
- EXPANDER-1 (NCT03758222)
- Testing
- XFLO Expander System
- Where
- 5 sites in Australia, Canada and 2 more
- Volunteers
- 45 people
- Sponsor
- MedeonBio, Inc.
Localised Prostate Cancer, Locally Advanced Prostate Cancer
MRI Guided Transurethral HIFU for Various Prostate Diseases
This study assesses feasibility and safety, the primary outcomes, of MRI guided transurethral high intensity focused ultrasound (HIFU) ablation for prostate diseases (PD).
- Conditions
- Localised Prostate Cancer, Locally Advanced Prostate Cancer, Locally Recurrent Prostate Cancer, Benign Prostatic Hyperplasia
- Trial name
- HIFU-PRO (NCT03350529)
- Testing
- MRI guided transurethral HIFU ablation of prostatic tissue
- Where
- Finland
- Volunteers
- 87 people
- Sponsor
- Turku University Hospital
Benign Prostatic Hyperplasia
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.
- Trial name
- NCT06157164
- Testing
- UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP)
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- University of Kansas Medical Center
Benign Prostatic Hyperplasia (BPH)
Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)
The current study is being conducted by the Sponsor to evaluate the efficacy and safety of GV1001 (0.56 mg and 1.12 mg) administered as a treatment for Benign prostate hyperplasia(BPH).
- Trial name
- NCT04032067
- Where
- 23 sites in South Korea
- Volunteers
- 423 people
- Sponsor
- GemVax & Kael
Benign Prostatic Hypertrophy With Outflow Obstruction, Overactive Detrusor
Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia
Persistent detrusor overactivity (DO) after transurethral prostatectomy results in symptomatic failure in more than one third of the patients.
- Trial name
- NCT01781117
- Testing
- Holmium Laser Enucleation of the Prostate (HoLEP), Holmium laser enucleation system and morcellator
- Where
- South Korea
- Volunteers
- 184 people, healthy volunteers welcome
- Sponsor
- KYU-SUNG LEE